10.20.Z - Processing and preserving of fish, crustaceans, and mollusks
20.42.Z - Manufacture of cosmetics and toilet preparations
21.10.Z - Manufacture of basic pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
46.38.Z - Wholesale trade of other food products
47.23.Z - Retail trade of fish, crustaceans, and mollusks
47.73.Z - Retail sale of pharmaceutical products
47.74.Z - Retail sale of medical and orthopedic products
52.10.B - Warehousing and storage of other goods
72.11.Z - Scientific research and development activities
2022 | 2023 | 2024 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 0,2 | 0,4 | 0,2 | -50,3 |
EBITDA | 0,4 | 0,7 | 0,4 | -45,8 |
Short time liabilities | 1,1 | 1,4 | 1,4 | -5,3 |
Equity capital | 3,2 | 3,5 | 3,7 | 4,3 |
Operating profit (EBIT) | 0,3 | 0,6 | 0,2 | -58 |
Assets | 5,7 | 6,2 | 6,2 | -0,8 |
Net profit (loss) | 0,1 | 0,3 | 0,2 | -52,7 |
Cash | 0,2 | 0,3 | 0,9 | 160,1 |
Net income from sale | 10,5 | 11,2 | 9,1 | -18,7 |
Liabilities and provisions for liabilities | 2,4 | 2,7 | 2,5 | -7,7 |
Working assets | 2,7 | 3,4 | 3,5 | 2,8 |
Depreciation | 0,2 | 0,1 | 0,1 | 0,3 |
% | % | % | p.p. | |
Profitability of capital | 4,3 | 9,1 | 4,1 | -5 |
Equity capital to total assets | 56,8 | 57,1 | 60 | 2,9 |
Gross profit margin | 1,6 | 3,4 | 2,1 | -1,3 |
EBITDA Margin | 4 | 6,3 | 4,2 | -2,1 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 38 | 47 | 54 | 7 |
Current financial liquidity indicator | 2.280654191970825 | 2.2444798946380615 | 2.467421770095825 | 0,3 |
Net dept to EBITDA | 3.9587838649749756 | 1.144653081893921 | 0.675157368183136 | -0,4 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane